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ABSTRACT
Introduction: Psychopathological symptoms are common during pregnancy and their detection and referral to specialized care is often 
suboptimal. The aim of this study was to perform a descriptive analysis of sociodemographic, mental health, and obstetric features of a 
population of pregnant women followed at Psychiatry consultation.
Methodology: This was a cross-sectional, descriptive study of women followed both at Gynecology/Obstetrics and Psychiatry consultations 
of Hospital Prof. Doutor Fernando Fonseca between 2014 and 2016. A total of 76 women were included, for whom pre-defined features 
associated in the literature with risk of developing psychopathological symptoms during pregnancy were collected.
Results and Discussion: Risk factors identified in the development of depressive symptoms included absence of an affective relationship 
during pregnancy (n=11; 14.5%), being first-generation immigrant (n=17; 22.4%), and substance use before (n=18; 23.7%) or during (n=10; 
13.1%) pregnancy. Sample was divided into women with previous Psychiatry follow-up who became pregnant (n=44; 57.9%) and women 
referred to Psychiatry consultation during pregnancy (n=32; 42.1%). In the second group, 18.8% (n=6) of referrals were from primary health 
care, being relevant to understand whether this represents an under-referral. Prescription of 21 risk category D drugs was identified, alerting 
to the need of caution in pharmacological prescription and of considering non-pharmacological options (e.g., cognitive-behavioral therapy) 
for management of these cases.
Conclusions: Risk factors identified in this study represent an opportunity to optimize clinical practice and improve these patients’ follow-up.
Keywords: mental health; perinatal care; pregnancy; psychopathology
RESUMO
Introdução: Alterações psicopatológicas são comuns durante a gravidez e a sua deteção e referenciação a cuidados especializados é 
frequentemente deficitária. O objetivo deste estudo foi efetuar uma análise descritiva de dados sociodemográficos, de saúde mental e 
obstétricos de uma amostra de grávidas em seguimento em consulta de Psiquiatria.
Material e Métodos:  Este foi um estudo transversal e descritivo. A amostra foi selecionada por cruzamento dos processos de doentes 
com seguimento em consulta de Ginecologia/Obstetrícia e Psiquiatria no Hospital Prof. Doutor Fernando Fonseca entre 2014 e 2016. Foram 
obtidos 76 processos, tendo sido colhidas e analisadas variáveis previamente identificadas na literatura como estando associadas a risco de 
desenvolvimento de alterações psicopatológicas durante a gravidez.
Resultados e Discussão: Foram identificados fatores de risco para o desenvolvimento de sintomas depressivos, nomeadamente ausência 
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de relacionamento afetivo durante a gestação (n=11; 14,5%), ser imigrante de 1ª geração (n=17; 22,4%) e consumos toxicofílicos antes 
(n=18; 23,7%) ou durante (n=10; 13,1%) a gravidez. A amostra foi dividida entre mulheres com acompanhamento pregresso em Psiquiatria 
que engravidaram (n=44; 57,9%) e mulheres referenciadas para consulta de Psiquiatria durante a gestação (n=32; 42,1%). Neste segundo 
grupo, 18,8% (n=6) das referenciações foram feitas a partir dos cuidados de saúde primários, sendo importante perceber se tal se trata de 
uma sub-referenciação. Foram prescritos 21 fármacos da categoria de risco D, o que alerta para a necessidade de precaução na prescrição 
farmacológica e de considerar alternativas não farmacológicas (e.g. terapia cognitivo-comportamental) na orientação destes casos.
Conclusões:  Este estudo permitiu identificar fatores de risco para psicopatologia, representando uma oportunidade de otimizar a prática 
clínica e o seguimento destas doentes.
Palavras-chave: cuidados perinatais; gravidez; psicopatologia; saúde mental
INTRODUCTION
Psychopathological symptoms are common during pregnancy. 
According to the literature, prevalence of psychiatric illness among 
pregnant women in clinical samples varies from 15% to 29%.1 These 
values may correspond to underdiagnosis and to subsyndromal 
levels of psychopathology.1,2 Psychiatric disorders, specifically with 
anxious and depressive symptoms, may have repercussions in 
pregnant women in the form of more frequent and pronounced 
accessory symptoms (such as vomiting or nausea) and increased risk 
of obstetric complications. However, they may also affect the child 
via biological (e.g., hypothalamic-pituitary-adrenal axis) or relational 
and developmental (e.g., changes in mother-infant bonding pattern, 
delays in cognitive and motor development) effects.3-5
Follow-up of pregnant women with psychiatric illness poses multiple 
difficulties, including regarding pharmacotherapeutic options, given 
gestation-related contraindications, risk of medication interruption 
or non-acceptance, risk of psychiatric symptom relapse, and need for 
urgent intervention regarding mental health to avoid negative effects 
on mother and fetus. In addition, psychopathological symptoms 
often go unnoticed in prenatal exams, and follow-up is sometimes 
insufficient.4,6 Some explanatory hypotheses for this lack of detection 
and adherence are related to health service providers, including 
psychopathology underdetection in Primary Health Care (PHC) 
and Obstetric Services, lack of psychoeducational information for 
women, lack of knowledge or absence of a systematic approach from 
professionals, and fear of case mismanagement or bad practice.4,7,8 
Some barriers to seeking screening and help are related to women 
themselves, such as preference to deal with mood problems on their 
own, fear of losing parental rights due to symptom disclosure, fear of 
medication, and not distinguishing which emotions are “normal” or 
not during pregnancy. Lack of family member involvement of other 
sources of social support can also hinder detection and treatment of 
mental health disorders.8,9 Additionally, economic (especially in low-
income women), logistical, and cultural/linguistical barriers should 
also be considered.10 
Several studies, mainly reviews and meta-analyses, have sought 
to untangle risk factors associated with development of anxious 
and depressive symptomatology during pregnancy. However, this 
association is more consistent in some studies than others. Absence 
of social support  (especially from partners), stressful life events, 
personal or family psychiatric history, substance abuse, obstetric 
complications during pregnancy, and unplanned pregnancy have 
all been associated with depressive symptoms during pregnancy.4,5 
Relevance of these factors in the population of pregnant women 
should be assessed, in order to plan targeted interventions.
Few studies are available in the literature describing psychopathology 
risk factors and how to refer and follow this group of patients. 
Therefore, the aim of this study was to conduct a descriptive analysis 
of sociodemographic, mental health, and obstetric features of a 
sample of pregnant women with follow-up both at Obstetrics and 
Psychiatry consultation of Hospital Prof. Doctor Fernando Fonseca 
(HFF), to investigate and improve knowledge about this patient 
population profile.
METHODS
This was a cross-sectional and descriptive study. Sample was obtained 
by cross-selecting patients with follow-up both at Gynecology/
Obstetrics and Psychiatry consultation of HFF between January 2014 
and December 2016. Inclusion criteria comprised patients (1) with at 
least one gestation during the considered three-year period and (2) 
referred to Psychiatry consultation during pregnancy or with follow-
up in Psychiatry before the beginning of pregnancy. 
Pre-defined socio-demographic (age, nationality, marital status), 
mental health (substance abuse before and during pregnancy, family 
history of psychopathology [namely during pregnancy], psychiatric 
diagnosis, psychopathological symptoms, psychotherapeutic and 
psychopharmacological treatment), and obstetric (gravidity and 
parity, obstetric complications in the considered pregnancy, risk 
pregnancy, unplanned or unwanted pregnancy) data were collected 
and described. 
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Data was retrieved from clinical records of the first Gynecology/
Obstetrics consultation and first Psychiatry consultation after 
pregnancy. To schematize data collection and description, sample 
was divided into a group of women with previous Psychiatry follow-
up who became pregnant during the considered three-year period 
− Group 1 (G1) − and a group of women who were already pregnant 
at the time of Psychiatry referral during that same period − Group 
2 (G2). In G1, data regarding socio-demographic and mental health 
features was retrieved from medical records of the first psychiatry 
consultation after pregnancy detection. In G2, the same data was 
retrieved from medical records of the first Psychiatry evaluation 
following referral. The only exception was that in G1 “substance 
abuse before pregnancy” data had to be verified in previous 
Psychiatry consultations. 
Descriptive statistical analysis was performed using the Statistical 
Package for Social Sciences®, version 23 and Microsoft Excel 2016®. 
Absolute and relative frequencies were used as descriptive measures, 
and mean (M) and standard deviation (SD) as central tendency 
measures.
RESULTS
Of 246 cases initially identified, 170 were excluded for not meeting 
inclusion criteria, namely for absence of at least one gestation during 
the considered time period or absence of psychiatric clinical data.
A total of 76 pregnant women were included in the study, with 
a mean (SD) age of 33.6 (±6.7) years. These were divided into two 
groups: women followed in Psychiatry before pregnancy (G1; n=44, 
57.9%) and women referred to  Psychiatry during pregnancy (G2; 
n=32, 42.1%; Figure 1). 
Figure 1 - Sample distribution and characterization according to referral before or during pregnancy
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Socio-demographic data of the two groups is presented in Table 1. 
Regarding marital status, 37 women (37.0%) were married and 14 
(18.4%) were in a common-law marriage. Although 25 women (32.9%) 
were single (n=18, 23.7%) or divorced (n=7, 9.2%), only 11 women 
(14.5%) denied having an affective relationship during pregnancy. 
Seventeen women (22.4%) were first-generation immigrants, while 
the remaining (n=59, 77.6%) had Portuguese nationality. 
At least 18 women (23.7%) reported substance use before 
pregnancy (tobacco n=16, 23.7%; cannabinoids n=4, 5.3%; alcohol 
n=3, 3.9%; cocaine n=2, 2.6%; LSD n=1, 1.3%). This number reduced 
to ten women (13.1%) during pregnancy (tobacco n=10, 13.2%; 
cannabinoids n=2, 2.6%), corresponding to a 55.6% decrease in 
substance use.
Obstetric health data is presented in Table 2, specifically obstetric 
complications during current pregnancy (n=22, 28.9%), classification 
as high-risk pregnancy (n=31, 40.8%), and occurrence of unplanned 
or unwanted pregnancies (n=26, 34.2%). Data regarding gravidity 
(M±DP 2.7±1.30) and parity (M±DP 1.4±1.12) is also presented. It 
should be noted that ten women were pregnant for the first time 
(13.2%) and 62 women were multiparous (81.6%).
Family history of psychiatric illness was established in 24 women 
(31.6%). However, presence or absence of family history of 
psychopathology during pregnancy was only registered in 14 clinical 
records (18.4%) and identified in two patients (2.6%). Thus, this 
information could not be retrieved from clinical records in 81.6% of 
cases (n=62). 
Table 3 depicts psychiatric diagnoses established by the psychiatrist 
according to ICD-10 classification. Most frequent diagnoses in G2 were 
depressive (n=10, 31.2%) and anxiety (n=9, 28.1%) disorders, such 
as panic disorder or generalized anxiety disorder. In G1, depressive 
episodes were also identified as the most frequent diagnosis (n=12, 
27.3%), and bipolar affective disorder as the second most common 
diagnosis (n=10, 22.7%).
Regarding treatment, 59 women (77.6%) were already receiving 
or started pharmacotherapy (G1 n=32, 42.1%; G2 n=27, 35.5%) and 
16 (21.1%) were receiving or started psychological counseling (G1 
n=9, 11.8%; G2 n=7, 9.2%). A total of 88 different medications were 
prescribed in consultation, 21 (23.9%) of which were category D 
drugs (17 of which benzodiazepines).
Table 1 - Descriptive analysis of socio-demographic variables
G1 G2 Total
n= % n= % n= %
Obstetric complications 
during pregnancy
     Yes 9 20.5 13 40.6 22 28.9
     No 35 79.5 19 59.4 54 71.1
High-risk pregnancy
     Yes 24 54.5 7 21.9 31 40.8
     No 30 45.5 25 78.1 45 59.2
Unplanned/unwanted 
pregnancy
     Yes 15 34.1 11 34.4 26 34.2
     No 29 65.9 21 65.6 50 65.8
Gravidity
     1 7 15.9 3 9.4 10 13.2
     2 16 36.4 12 37.5 28 36.8
     3 10 22.7 13 40.6 23 30.3
     ≥4 11 25.0 4 12.5 15 19.7
Parity
     0 10 22.7 4 12.5 14 18.4
     1 20 45.5 13 40.6 33 43.4
     2 7 15.9 12 37.5 19 25.0
    ≥3 7 15.9 3 9.4 10 13.2
Total 44 100.0 32 100.0 76 100.0
Table 2 - Descriptive analysis of maternal-fetal health data
G1 G2 Total
n= % n= % n= %
Marital Status
     Married 15 34.1 22 68.8 37 48.7
     Single      12 27.3 6 18.8 18 23.7
     Common-law marriage 12 27.3 2 6.3 14 18.4
     Divorced 5 11.4 2 6.3 7 9.2
Affective relationship
during pregnancy 
     Yes 38 86.4 27 84.4 65 85.5
     No 6 13.6 5 15.6 11 14.5
Nationality
     Portuguese 36 81.8 23 71.9 59 77.6
     Non-Portuguese 8 18.2 9 28.1 17 22.4
Total 44 100.0 32 100.0 76 100.0
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DISCUSSION
Results from this analysis identified risk factors for psychopathology 
in pregnant women. Some are potentially manageable through 
proper referral and health care surveillance.
These women’s family and social support during medical follow-up 
or through the help of other professionals is relevant and should be 
investigated. Lack of social support, poor relationship, or absence 
of a partner during pregnancy are frequently cited as possible risk 
factors for anxious or depressive symptoms.4,5 The percentage of 
women with no affective relationship in this sample was 14.5%. A 
study by Maia T (2014) that assessed determinants of mother-infant 
relationship in a sample of pregnant women (n=92) followed at PHC 
maternal health consultation in the same geographic area of the 
present study reported that 25.0% of women were single/separated, 
with a higher prevalence of depression in this subgroup.11 This value 
Table 3 - Clinical diagnoses (according to ICD-10 classification) 
attributed by psychiatrists
G1 G2 Total
n= % n= % n= %
F10 (Alcohol related 
disorders)
1 2.3 0 0 1 1.3
F29 (Unspecified 
psychosis not due to 
a substance or known
physiological condition)
0 0 1 3.1 1 1.3
F31 (Bipolar disorder) 10 22.7 1 3.1 11 14.5
F32 (Major depressive 
disorder, single episode)
12 27.3 10 31.3 22 29.0
F33 (Major depressive
disorder, recurrent)
2 4.5 1 3.1 3 4.0
F34 (Persistent mood 
disorders)
5 11.4 2 6.3 7 9.2
F41 (Other anxiety 
disorders)
4 9.1 9 28.1 13 17.1
F43 (Reaction to severe 
stress, and adjustment
disorders)
1 2.3 3 9.4 4 5.3
F44 (Dissociative and 
conversion disorders)
1 2.3 1 3.1 2 2.6
F60 (Specific personality 
disorders)
6 13.6 3 9.4 9 11.8
F70 (Mild intellectual 
disabilities)
2 4.5 0 0 2 2.6
No psychiatric disorder 0 0 1 3.1 1 1.3
Total 44 100.0 32 100.0 76 100.0
was higher in the present study (32.9%), reinforcing the urgent need 
for attention to these women.
In this study, the proportion of first-generation immigrant women 
(22.4%) was higher than the proportion of foreign women among 
hospital patients (8%).12 According to the literature, immigrant 
mothers have increased psychological vulnerability, particularly in 
the postpartum.13,14  A study by Almeida LM et al. (2016) found an 
increased risk of postpartum depression and lower satisfaction with 
social support among migrant mothers.14 In addition, disparities in 
psychopathology diagnostic and treatment rates in migrant women 
tend to occur, with cultural and linguistic barriers to access and 
continued health care as possible explanations.13 In the study by 
Maia T (2014), 34.8% of pregnant women were first-generation 
immigrants, and this was associated with a higher depression 
prevalence.11 Hence, the high representativeness of this subgroup in 
this study and its association with depressive symptomatology risk 
alerts to the need for particular focus on integration and follow-up of 
these women, namely at PHC. 
In this study, the percentage of women with substance use during 
pregnancy was comparable to other studies (Cook et al., 2017) 
regarding tobacco (13.2% vs. 12-25%) and cannabinoid (2.6% vs. 1.8-
16.6%) smoking, while alcohol and other illicit substance consumption 
was null.15 A 55.6% decrease in these consumptions was  reported 
between the period before and during gestation (62.5% tobacco 
reduction, 50% cannabinoids reduction, and alcohol, cocaine, and 
LSD withdrawal). However, it is acknowledged that this reduction is 
not always maintained, with frequent relapses during postpartum. 
Substance use is one of risk factors with greater intervention 
potential, especially when compared to factors intrinsic to women 
and their family.5,15 Therefore, it should be a primary intervention 
target, with referral to specialized teams whenever necessary and 
appropriate psychoeducation during consultation. It should also be 
noted that retrieved figures may be underestimated due to women 
or physician underreporting.
 Although family history of psychopathology can be perceived, its 
presence or absence during pregnancy was often not registered 
by clinicians in anamnesis. This factor should be considered when 
assessing psychopathology risk in pregnancy and postpartum, as 
some studies suggest that perinatal depression (and particularly 
postpartum depression) has a familial component.16 Thus, this 
data should be systematically collected during clinical practice 
consultations.
In this sample, 26 women (34.2%) admitted having an unwanted 
or unplanned pregnancy, what is associated with angodepressive 
symptomatology in the literature.4,5,17 Unwanted or unplanned 
pregnancies should be evaluated in clinical practice, as well as 
existence of social and economic support, as they will not necessarily 
translate into harmful consequences if properly managed. 
A positive association between obstetric risk and depression rate 
is reported in the literature.4,17 In this sample, a high percentage of 
obstetric complications during pregnancy (n=22, 28.9%) and high-
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risk pregnancy (n=31, 40.8%) was uncovered. However, the bias 
intrinsic to “high-risk pregnancy” criteria should be considered. In 
the hospital where this data was collected, criteria for potential 
high-risk pregnancy includes being less than 18 or over 35 years old; 
presenting comorbid medical pathologies (arterial hypertension, 
diabetes, autoimmune disease, endocrine pathology, etc.); being 
previously followed at Psychiatry; and presenting placenta previa. 
Those women previously attend a screening visit, in which those who 
maintain high-risk patient classification during follow-up are selected. 
This process has intrinsic variability, and the high percentage of high-
risk pregnancies in G1 (54.5%) and proportion of women referred 
from obstetrics in G2 possibly reflect this.
The association between parity and psychopathology risk during 
pregnancy has been investigated, with conflicting results. Previous 
studies showed a correlation between depressive symptoms during 
pregnancy and both lower and higher parity.4 Some studies report no 
differences regarding this, such as the study by Bassi (2017), which 
found that depression levels did not differ between primiparous 
and multiparous women.18 A study by Sockol (2015) suggested that 
multiparous women had higher levels of certain depression and 
anxiety risk factors, particularly interpersonal risk factors, which 
could be addressed in therapeutic interventions.19  Moreover, the 
same author proposed that primiparous women would benefit from 
cognitively-focused interventions, while mothers with older children 
would benefit from family-based or interpersonal interventions. 
In the present study, this second stance is particularly valuable 
among 81.2% multiparous women, suggesting that family-based and 
interpersonal interventions should be considered when designing a 
therapeutic plan for these patients.
Distribution according to previous referral or during pregnancy
G2 had a predominance of referrals from the Obstetric Department 
(56.3%) compared with PHC (18.8%). Considering that the greater 
pregnancy volume is followed at PHC, it is relevant to understand if 
this represents an under-referral and how that could be optimized. 
To facilitate pregnant women access to and follow-up in specialized 
care, studies have recommended measures − including adapted 
follow-up models (e.g., schedules adjusted to prenatal consultations) 
−, protocols for detection and guidance of women at risk − namely 
in PHC and Obstetrics, possibly involving screening surveys −, and 
better articulation between PHC, Obstetrics, and Psychiatry services. 
Women with severe prior psychiatric illness, namely in peripartum, 
and with other important risk factors, should be referred to 
Psychiatry.5,7 
Predominance of depressive and anxious symptomatology 
was observed in both groups, in line with the most frequent 
psychopathological symptoms reported during pregnancy.1,2,4 A 
similar pattern was observed for ICD-10 diagnoses in women referred 
to consultation during pregnancy. However, a high prevalence of 
women with  bipolar affective disorder diagnosis was observed in 
G1, in agreement with the fact that these women had longitudinal 
follow-up in Psychiatry. In women with previously recognized 
psychiatric disease, resurgence of symptoms or new episodes during 
pregnancy and puerperium should be focused.
Therapeutic approach
In a study by Ferracini et al (2017) evaluating 305 medical 
prescriptions for 58 women (31 pregnant, 27 breastfeeding) and 
respective risk category (according to FDA classification), 15 (13.8%) 
received category D and 2 (1.8%) category X drugs.20 Using the same 
classification, prescription of 21 category D drugs – corresponding 
to 23.9% of all prescriptions − during pregnancy was detected in 
this study. Besides noteworthy by itself, this percentage is superior 
to Ferracini study. Within chosen antidepressants, and as expected 
from other samples and guidelines, selective serotonin reuptake 
inhibitors (mainly sertraline) have been more frequently used.6,21,22 
A meta-analysis by Van Ravensteyn (2017) found a robust moderate 
effect of cognitive-behavioral therapy for major depression during 
pregnancy and positive results for body-oriented interventions.23 This 
prompts reflection on the role of non-pharmacological approaches 
as legitimate treatment options for these patients.
The main limitations of this study are its cross-sectional nature, 
which prevents causality inference, relatively small sample size, and 
possible selection bias (e.g., exclusion of women followed in private 
practice in both specialties). 
CONCLUSION
This study describes risk factors and characteristics of pregnant 
women followed in Psychiatry. Retrieved results identified some 
critical points that should be object of intervention. It is vital to 
perceive these women’s social support network, especially in the 
immigrant subpopulation. Incisive action should be taken regarding 
substance use cessation during and after pregnancy. Referral and 
longitudinal follow-up of women with high-risk pregnancies and/
or psychopathology should also be addressed.  Referral from PHC 
accounted only for a small percentage of cases in this sample, what 
should be investigated and involvement of these professionals 
promoted. Finally, clinicians should carefully explore existing 
pharmacological and non-pharmacological treatment options (e.g., 
cognitive-behavioral therapy, body oriented interventions) and avoid 
prescription of category D or X drugs, namely benzodiazepines.
In summary, this study enabled to identify existing risk factors and 
specific features associated with this population referral. Retrieved 
results prompt reflection on mental disease during pregnancy and its 
management in PHC, Obstetrics, and Psychiatry services and indicate 
aspects requiring special attention from health professionals and 
with the potential to be integrated in clinical practice
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